Skip to main content

UK Biotech Group Contributes $74M to EU Systems Bio Initiatives

NEW YORK (GenomeWeb News) — A group of European nations are firing up a new multinational initiative to fund projects that apply systems biology principles to the study of single-cell animals, a UK research group said yesterday.
The UK-based Biotechnology and Biological Sciences Research Council contributed ₤37.4 million ($74 million) to the projects, collectively called the Systems Biology of Microorganisms Program.
BBSRC said it will work with German and Dutch scientists to study the Clostridium acetobutylicum bacterium, which is used in the production of a potential biofuel called butanol.
The group said this bacterium also is a cause of hospital infections, and suggested the research may offer knowledge that could be useful in combating those as well.
Another study looks into extremophiles to try to learn more about how temperature affects the biological pathways inside these organisms. 
And another project would study why “small genetic differences cause stark and important differences in species,” and would look in particular at Lactococcus lactis, Enterococcus faecalis, and Streptococcus pyogenes.
Though all of these bacteria convert sugar lactose into lactic acid, one causes toxic shock syndrome. 
Other nations involved in the project include Spain, Norway, Germany, Austria, the Netherlands, France, the Czech Republic, and Switzerland.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.